Development of Simultaneous Drug Concentration Measurement Method Using an Automated Pretreatment Liquid Chromatography/Tandem Mass Spectrometry System for Therapeutic Drug Monitoring

• Egile Nagusiak: Yu Sato (Egilea), Hiroki Kondo (Egilea), Yuji Sato (Egilea), Ai Abe (Egilea), Masafumi Kikuchi (Egilea), Toshihiro Sato (Egilea), Masaki Kumondai (Egilea), Kohei Yoshikawa (Egilea), Yoshihiro Hayakawa (Egilea), Masamitsu Maekawa (Egilea), Nariyasu Mano (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2024-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Therapeutic drug monitoring (TDM) is a personalized treatment approach that involves optimizing drug dosages based on patient-specific factors, such as drug plasma concentrations, therapeutic efficacy, or adverse reactions. The plasma concentration of drugs is determined using liquid chromatography/...